Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04559516

Remote Exercise Program Delivery Using a Mobile Application for Pulmonary Arterial Hypertension

Remote Exercise Program deliVery Using A Mobile Phone Application for Patients With Pulmonary Arterial Hypertension (REVAMP): a Pilot Randomized Trial

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will determine the feasibility of a mobile application-based home exercise rehabilitation program for patients with pulmonary hypertension.

Detailed description

Pulmonary rehabilitation programs that incorporate exercise training are an important component of optimal medical care for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), which improves exercise performance, quality of life, and may even modify disease progression. To date, no studies have utilized mobile health (mHealth) technology to provide exercise program interventions in the pulmonary hypertension population. Leveraging mobile technology, such as smartphones or tablets, to administer a home-based exercise rehabilitation program could improve patient access, satisfaction, and participation, while providing sustained physiologic benefits and incurring major cost savings compared to inpatient or outpatient-based supervised programs. This study hypothesis is that a home-based exercise program delivered by a mobile app will be feasible and safe for PAH/CTEPH patients. The secondary outcomes assessed will explore whether there are changes in exercise capacity, health-related quality of life, and right ventricular function, compared to standard care.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExercise InterventionThe Ethica mobile app will provide a daily alert accompanied by a short educational statement about PAH, disease self-management tips, dietary and nutritional advice, goal setting, and a motivational statement to encourage patients. Participation with each session will be assessed by a mobile app-embedded survey administered at the end of the day. Patients will be presented with weekly alerts to complete validated patient-reported quality of life questionnaires using the EmPHasis-10 and the Living with Pulmonary Hypertension Questionnaire, as well as the PRAISE self-efficacy score for pulmonary rehabilitation. The app will also ask patients to report their WHO/NYHA functional class every week. Using in-app buttons, participants can log adverse events associated with each exercise session.
BEHAVIORALStandard CareParticipants will be provided usual care administered at the PH clinic at the University of Calgary and no supervised exercise session will be performed.

Timeline

Start date
2022-11-03
Primary completion
2022-11-03
Completion
2022-11-03
First posted
2020-09-23
Last updated
2022-11-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04559516. Inclusion in this directory is not an endorsement.